Kit and method for identifying common varieties of leeches

Through specific primer sets and PCR identification methods, the problem of identifying leech medicinal materials varieties is solved, rapid and accurate identification is achieved, and the quality and efficacy of medicinal materials are guaranteed.

CN118910274APending Publication Date: 2024-11-08HAINAN YANGSHEGTANG PHARMA CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411059866.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-08-28
Filing Date
2024-08-02
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

It is difficult to accurately and quickly identify the varieties of leech medicinal materials in the prior art, which makes it difficult to guarantee the quality and clinical efficacy of medicinal materials.

Method used

Specific primer sets and PCR identification methods based on these primers are provided, and through nucleic acid extraction and fluorescence signal detection, the luminous gold thread leech, wide-body gold thread leech and phenanthirst can be quickly and accurately identified.

Benefits of technology

The rapid and accurate identification of leech medicinal materials has been achieved, ensuring the quality of medicinal materials and the safety and efficacy of clinical medicines.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The invention provides a primer for identifying common varieties of leeches, a kit containing the primer and a method for identifying the common varieties of the leeches by using the primer or the kit.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the fields of biotechnology and traditional Chinese medicine, and in particular to primers for identifying common leech varieties, a kit containing the primers, and a method for identifying common leech varieties using the primers or the kit. Background Art

[0002] Leeches were first recorded in Shennong's Herbal Classic and were listed as low-grade medicines. "Leech tastes salty and flat. They are mainly used to expel bad blood, treat blood stasis and amenorrhea, break up blood masses, and treat infertility, and promote urination." The 2020 edition of the Chinese Pharmacopoeia stipulates that leeches are the dried whole body of the Hirudinidae leech (Wide-bodied Golden Leech) Whitmania pigra Whitman, Hirudo nipponica Whitman, or Whitmania acranulata Whitman. It has the effects of breaking blood and promoting menstruation, removing blood stasis and eliminating symptoms, and can be used for blood stasis and amenorrhea, lumps and masses, hemiplegia caused by stroke, and injuries caused by falls. Leeches are traditional Chinese medicines for promoting blood circulation and removing blood stasis. They have pharmacological effects such as anticoagulation, antithrombosis, antitumor, lipid-lowering, anti-inflammatory, anti-fibrosis, brain protection, and anti-nerve damage. They are mostly used in the treatment of stroke, heart failure, multiple cerebral thrombosis, etc. At present, the main commercial varieties are broad-bodied golden leeches, but the Philippine cattle leech Poecilobdella manillensis Lesson is also a traditional Chinese medicine. It has been included in the "Guangxi Zhuang Autonomous Region Zhuang Medicine Quality Standard Zhuang Pharmacopoeia" and "Yunnan Province Traditional Chinese Medicine Standard" as a local specialty medicine; in addition, the smooth golden leech Whitmania laevis Whitman is often circulated in the market as a counterfeit of the sharp golden leech.

[0003] In recent years, due to the complexity of leech origin and the sharp increase in leech market demand, it is urgent to establish an accurate and effective method for leech authenticity identification to provide strong guarantee for the clinical medication safety and efficacy of leech medicinal materials. Traditional identification methods often have certain limitations due to the influence of genetic variability, phenotypic plasticity, and complexity of chemical composition.

[0004] In order to ensure the quality and clinical efficacy of leech medicinal materials in the medicinal materials market, it is necessary to establish a fast, accurate, scientific and easy-to-use method for identification. Summary of the invention

[0005] Based on a large amount of research and screening, the inventors of the present application have obtained primers that can quickly and accurately identify commonly used leech species in medicinal materials (for example, Hirudo glabrata, Hirudo latifolia, Hirudo philadelphica) and an identification method based on the primers.

[0006] Therefore, in a first aspect, the present application provides a primer set comprising: (i) a primer A having a sequence as shown in SEQ ID NO:5 and a primer B having a sequence as shown in SEQ ID NO:6; or, (ii) a primer A' having a sequence as shown in SEQ ID NO:3 and a primer B' having a sequence as shown in SEQ ID NO:4.

[0007] In a second aspect, the present application provides a method for identifying a leech sample, the identification method being used to identify whether the leech sample to be tested is Hirudo glabrata, Hirudo glabrata or Hirudo philadelphica, and comprising the step of using the primer set described in the first aspect.

[0008] In certain embodiments, the leech sample to be tested contains only leeches of a single species. For example, the leech sample to be tested may contain leeches of a single species from a single batch from a single source; or the leech sample to be tested may contain leeches of a single species from multiple batches from multiple different sources.

[0009] In certain embodiments, the leech sample to be tested is a traditional Chinese medicine sample (eg, a traditional Chinese medicine material sample).

[0010] As used herein, the term "smooth golden leech", Whitmania laevis Whitman, also known as golden leech, has the meaning commonly understood by those skilled in the art. In certain embodiments, the smooth golden leech has one or more appearance characteristics selected from the following: (1) spindle-shaped, (2) 3.2 to 8.1 cm long, (3) 0.5 to 1.2 cm wide, (4) olive green to brown on the back, (5) 5 longitudinal stripes composed of yellow spots, the middle one is wider, and the two sides are light yellow longitudinal stripes, (6) the ventral surface is grayish white, (7) there are two longitudinal rows of dark brown spots on both sides of the ventral surface, (8) there are some irregularly arranged scattered spots on the ventral surface, (9) the number of body rings is 107, (10) the male hole is located in the center of the 34th ring, and the female hole is located in the center of the 39th ring, (11) the front sucker is small. In certain embodiments, the smooth golden leech meets the relevant records under the corresponding species in "Zoological Records of China", the entire text of which is incorporated herein by reference.

[0011] As used herein, the term "Witmania pigra Whitman", also known as leech, has the meaning commonly understood by those skilled in the art. In certain embodiments, the Whitmania pigra Whitman has one or more appearance characteristics selected from the following: (1) flat spindle-shaped, (2) with many segments, (3) 4 to 10 cm long, (4) 0.5 to 2 cm wide, (5) dark brown or dark brown on the back, (6) slightly raised on the back, (7) after soaking in water, black spots can be seen on the back arranged in 5 longitudinal stripes, (8) flat ventral surface, (9) brown-yellow on the abdomen, (10) brown-yellow on both sides, (11) slightly pointed at the front end, (12) blunt at the rear end, (13) 1 sucker at each end, (14) the sucker at the front end is not obvious, and (15) the sucker at the rear end is larger. The Whitmania pigra Whitman is usually used to treat blood stasis, amenorrhea, accumulation of lumps and other indications. In certain embodiments, the Hirudo wilfordii complies with the relevant provisions of the Chinese Pharmacopoeia (2020 edition) under the main text of medicinal materials, the entire text of which is incorporated herein by reference.

[0012] As used herein, the term "Poecilobdella manillensis Lesson", also known as the golden-edged leech, has the meaning commonly understood by those skilled in the art. In certain embodiments, the Philippine cattle leech has one or more of the following appearance characteristics: (1) oblong, long strip or twisted, flat, willow-shaped, (2) 4 to 13 cm long, (3) 0.3 to 1.2 cm wide, (4) 0.05 to 0.1 cm thick, (5) dark brown or black on the back, (6) with a few protruding segments on the back, (7) black on the ventral surface, (8) relatively smooth on the ventral surface, (9) slightly pointed at the front end, (10) blunt at the rear end, (11) with a sucker at each end, (12) the sucker at the front end is not obvious, and (13) the sucker at the rear end is large and round. In certain embodiments, the Philippine cattle leech is usually used to treat thrombosis and hyperlipidemia. In certain embodiments, the Philippine leech complies with the relevant provisions under the corresponding medicinal materials in the "Guangxi Zhuang Autonomous Region Zhuang Medicine Quality Standard Zhuang Pharmacopoeia" and the "Yunnan Province Traditional Chinese Medicine Standard", the entire text of which is incorporated herein by reference.

[0013] In certain embodiments, the identification method comprises:

[0014] (1) providing: nucleic acid derived from the leech sample to be tested, and the primer set of the first aspect;

[0015] (2) contacting the nucleic acid derived from the leech sample to be tested with the primer set of the first aspect and performing a PCR reaction;

[0016] (3) Evaluate whether the leech sample to be tested is Hirudo glabra, Hirudo glabra or Hirudo philadelphica.

[0017] In certain embodiments, the nucleic acid derived from the leech sample to be tested is DNA (eg, genomic DNA).

[0018] In certain embodiments, in step (1), the identification method provides nucleic acid derived from the leech sample to be tested by extracting and / or purifying nucleic acid from the leech sample to be tested.

[0019] In certain embodiments, the identification method provides nucleic acid derived from the leech sample to be tested by extracting and / or purifying nucleic acid from the leech sample to be tested by the following steps:

[0020] (a) using SDS lysate and proteinase K solution to precipitate tissue fragments and DNA in the leech sample to be tested;

[0021] (b) using phenol extraction to provide nucleic acid derived from the leech sample to be tested.

[0022] In certain embodiments, in step (3), whether the leech sample to be tested is Hirudo glabrata, Hirudo latifolia and / or Hirudo philadelphica is determined by detecting the specific amplification product of the PCR reaction.

[0023] In certain embodiments, the identification method detects specific amplification products of the PCR reaction by nucleic acid electrophoresis (eg, agarose nucleic acid electrophoresis).

[0024] In certain embodiments, the identification method detects the specific amplification product of the PCR reaction by a fluorescent signal. For example, in step (2) of the identification method, the PCR reaction is a fluorescent quantitative PCR reaction. In certain embodiments, in step (2), the identification method includes contacting the nucleic acid derived from the leech sample to be tested and the primer set of the first aspect with a fluorescent dye or a fluorescent probe; wherein the fluorescent dye is a fluorescent DNA binding dye, and the fluorescent probe is a fluorescent probe that can specifically bind to the PCR reaction product. In certain embodiments, the 5' end of the fluorescent probe is connected to a fluorescent group, and the 3' end is connected to a fluorescent quenching group; or, the 3' end of the fluorescent probe is connected to a fluorescent group, and the 5' end is connected to a fluorescent quenching group. In certain embodiments, the fluorescent group is selected from a FAM fluorescent group, a ROX fluorescent group, and a HEX fluorescent group.

[0025] In certain embodiments, the primer set is as defined in (i) of the first aspect. In certain embodiments, the primer set can specifically detect the sleek leech in Sleek leech, Sleek leech and Hirudo philadelphus. In certain embodiments, the primer set can specifically detect the sleek leech in Sleek leech, Sleek leech, Hirudo philadelphus, Hirudo philadelphus and Hirudo philadelphus.

[0026] In certain embodiments, in step (3), if there is a specific amplification product of the PCR reaction, it indicates that the leech sample to be tested is Hirudo glabrata.

[0027] In certain embodiments, the primer set is as defined in (ii) of the first aspect. In certain embodiments, the primer set can detect broad-bodied golden leech and Philippine cattle leech in golden leech, broad-bodied golden leech and Philippine cattle leech. In certain embodiments, the primer set can specifically detect broad-bodied golden leech and Philippine cattle leech in golden leech, broad-bodied golden leech, Philippine cattle leech, Japanese medicinal leech and pointed golden leech.

[0028] In certain embodiments, in step (3), if there is a PCR reaction-specific amplification product, it indicates that the leech sample to be tested is Hirudo philadelphica or Hirudo philadelphica.

[0029] In certain embodiments, in step (3), if there is a PCR reaction-specific amplification product, and the leech sample to be tested has the appearance characteristics of Hirudo scutellaria, it indicates that the leech sample to be tested is Hirudo scutellaria.

[0030] In certain embodiments, the appearance characteristics of the broad-bodied golden leech are selected from one or more of the following:

[0031] (1) Flat spindle-shaped, (2) Contains many segments, (3) 4-10 cm long, (4) 0.5-2 cm wide, (5) The back is dark brown or black-brown, (6) The back is slightly raised, (7) After soaking in water, black spots can be seen on the back arranged in 5 longitudinal stripes, (8) The ventral surface is flat, (9) The abdomen is brown-yellow, (10) Both sides are brown-yellow, (11) The front end is slightly pointed, (12) The rear end is blunt and rounded, (13) There is a sucker at each end, (14) The front end sucker is not obvious, (15) The rear end sucker is larger.

[0032] In certain embodiments, in step (3), if there is a PCR reaction-specific amplification product, and the leech sample to be tested has the appearance characteristics of a wide-bodied golden line leech that is different from the Philippine leech, it indicates that the leech sample to be tested is a wide-bodied golden line leech.

[0033] In certain embodiments, the appearance characteristics of the broad-bodied golden line leech that are different from the Philippine cattle leech (that is, the appearance characteristics that the broad-bodied golden line leech has but the Philippine cattle leech does not have) are selected from one or more of the following:

[0034] (i) It is flat and spindle-shaped, (ii) It has many segments, (iii) It is 4 to 10 cm long, (iv) It is 0.5 to 2 cm wide, (v) It has a raised back, (vi) After being soaked in water, black spots can be seen on the back arranged in 5 longitudinal stripes, (vii) The ventral surface is flat, and (viii) The abdomen is brown-yellow.

[0035] In certain embodiments, in step (3), if there is a specific amplification product of the PCR reaction, and the leech sample to be tested has the appearance characteristics of Hirudo philadelphica, it indicates that the leech sample to be tested is Hirudo philadelphica.

[0036] In certain embodiments, the appearance characteristics of the Philippine leech are selected from one or more of the following:

[0037] (1) Long oval, long strip, or twisted, flat, willow-leaf-shaped; (2) 4-13 cm long; (3) 0.3-1.2 cm wide; (4) 0.05-0.1 cm thick; (5) dark brown or black on the back; (6) with a few protruding segments on the back; (7) black on the ventral side; (8) relatively smooth on the ventral side; (9) slightly pointed at the front end; (10) blunt at the rear end; (11) with a sucker at each end; (12) the sucker at the front end is not obvious; (13) the sucker at the rear end is large and round.

[0038] In certain embodiments, in step (3), if there is a PCR reaction-specific amplification product, and the leech sample to be tested has the appearance characteristics of the Philippine leech that is different from the wide-bodied golden line leech, it indicates that the leech sample to be tested is the Philippine leech.

[0039] In certain embodiments, the appearance characteristics of the Philippine cattle leech that are different from the wide-bodied golden line leech (that is, the appearance characteristics that the Philippine cattle leech has but the wide-bodied golden line leech does not have) are selected from one or more of the following:

[0040] (i) It is oblong, long, or twisted, flat, willow-leaf-shaped, (ii) 4 to 13 cm long, (iii) 0.3 to 1.2 cm wide, (iv) 0.05 to 0.1 cm thick, (v) black on the ventral surface, and (vi) relatively smooth on the ventral surface.

[0041] In a third aspect, the present application provides a method for detecting whether a sample to be tested contains a golden leech, which includes the step of using a primer set, wherein the primer set comprises: a primer A having a sequence as shown in SEQ ID NO:5 and a primer B having a sequence as shown in SEQ ID NO:6.

[0042] In some embodiments, the primer set can specifically detect the slew in the slew, the broad-bodied leech and the Philippine cattle leech. In some embodiments, the primer set can specifically detect the slew in the slew, the broad-bodied leech, the Philippine cattle leech, the Japanese leech and the sharp leech.

[0043] In certain embodiments, the sample to be tested may include leeches from one or more species. For example, the sample to be tested may include leeches from a single batch of a single source and belonging to the same species; the sample to be tested may also include leeches from multiple batches of the same species or multiple species from multiple different sources.

[0044] In certain embodiments, the sample to be tested is a traditional Chinese medicine sample (eg, a traditional Chinese medicine material sample).

[0045] In certain embodiments, the detection method comprises:

[0046] (1) providing: a nucleic acid derived from the sample to be tested, and the primer set;

[0047] (2) contacting the nucleic acid derived from the sample to be tested with the primer set and performing a PCR reaction;

[0048] (3) Evaluate whether the sample to be tested contains Hirudovirus glabrata.

[0049] In certain embodiments, the nucleic acid derived from the test sample is DNA (eg, genomic DNA).

[0050] In certain embodiments, in step (1), the detection method provides nucleic acid derived from the sample to be tested by extracting and / or purifying nucleic acid from the sample to be tested.

[0051] In certain embodiments, the detection method provides nucleic acid derived from the sample to be tested by extracting and / or purifying nucleic acid from the sample to be tested by the following steps:

[0052] (a) using SDS lysis solution and proteinase K solution to precipitate tissue fragments and DNA in the sample to be tested;

[0053] (b) using phenol extraction to provide nucleic acid derived from the sample to be tested.

[0054] In certain embodiments, in step (3), whether the sample to be tested contains Hirudovirus is determined by detecting the specific amplification product of the PCR reaction.

[0055] In certain embodiments, the detection method detects specific amplification products of the PCR reaction by nucleic acid electrophoresis (eg, agarose nucleic acid electrophoresis).

[0056] In certain embodiments, the detection method detects the specific amplification product of the PCR reaction by a fluorescent signal. For example, in step (2) of the detection method, the PCR reaction is a fluorescent quantitative PCR reaction. In certain embodiments, in step (2), the detection method includes contacting the nucleic acid derived from the sample to be tested and the primer set with a fluorescent dye or a fluorescent probe; wherein the fluorescent dye is a fluorescent DNA binding dye, and the fluorescent probe is a fluorescent probe that can specifically bind to the PCR reaction product. In certain embodiments, the 5' end of the fluorescent probe is connected to a fluorescent group, and the 3' end is connected to a fluorescent quenching group; or, the 3' end of the fluorescent probe is connected to a fluorescent group, and the 5' end is connected to a fluorescent quenching group. In certain embodiments, the fluorescent group is selected from a FAM fluorescent group, a ROX fluorescent group, and a HEX fluorescent group.

[0057] In certain embodiments, in step (3), if a specific amplification product of the PCR reaction is present, it indicates that the sample to be tested contains Hirudovirus glabrata.

[0058] In a fourth aspect, the present application provides a kit comprising: (a) a first primer having a sequence as shown in SEQ ID NO: 5, and / or a second primer having a sequence as shown in SEQ ID NO: 3;

[0059] as well as,

[0060] (b) a third primer having a sequence as shown in SEQ ID NO: 6 or 4.

[0061] In certain embodiments, the kit further comprises a fluorescent dye or a fluorescent probe; wherein the fluorescent dye is a fluorescent DNA binding dye, and the fluorescent probe is a fluorescent probe that can specifically bind to a PCR reaction product.

[0062] In some embodiments, the fluorescent probe has a fluorescent group connected to the 5' end and a fluorescent quenching group connected to the 3' end; or, the fluorescent probe has a fluorescent group connected to the 3' end and a fluorescent quenching group connected to the 5' end. In some embodiments, the fluorescent group is selected from FAM fluorescent group, ROX fluorescent group, HEX fluorescent group.

[0063] In certain embodiments, the kit further comprises reagents for nucleic acid extraction and / or purification.

[0064] In certain embodiments, the kit further comprises reagents required for a PCR reaction (eg, DNA polymerase and / or dNTPs).

[0065] In a fifth aspect, the present application provides a kit comprising: (i) a primer A having a sequence as shown in SEQ ID NO:5 and a primer B having a sequence as shown in SEQ ID NO:6; and / or, (ii) a primer A' having a sequence as shown in SEQ ID NO:3 and a primer B' having a sequence as shown in SEQ ID NO:4.

[0066] In certain embodiments, the kit further comprises a fluorescent dye or a fluorescent probe; wherein the fluorescent dye is a fluorescent DNA binding dye, and the fluorescent probe is a fluorescent probe that can specifically bind to a PCR reaction product.

[0067] In some embodiments, the fluorescent probe has a fluorescent group connected to the 5' end and a fluorescent quenching group connected to the 3' end; or, the fluorescent probe has a fluorescent group connected to the 3' end and a fluorescent quenching group connected to the 5' end. In some embodiments, the fluorescent group is selected from FAM fluorescent group, ROX fluorescent group, HEX fluorescent group.

[0068] In certain embodiments, the kit further comprises reagents for nucleic acid extraction and / or purification.

[0069] In certain embodiments, the kit further comprises reagents required for a PCR reaction (eg, DNA polymerase and / or dNTPs).

[0070] In the sixth aspect, the present application provides the use of the primer set of the first aspect or the kit of the fourth aspect or the fifth aspect in detecting Hirudo glabra, Hirudo glabra and / or Hirudo philadelphus, or in preparing a detection reagent for detecting Hirudo glabra, Hirudo glabra and / or Hirudo philadelphus.

[0071] Advantageous Effects of the Invention

[0072] The primers provided in the present application and the method for using the primers can quickly and accurately identify the leech species commonly used in medicinal materials (for example, Hirudo glabra, Hirudo latifolia, Hirudo philadelphica), thereby providing strong guarantees for the clinical medication safety and efficacy of leech medicinal materials.

[0073] Embodiments of the present invention will be described in detail below in conjunction with the accompanying drawings and examples, but it will be appreciated by those skilled in the art that the following drawings and examples are only used to illustrate the present invention, rather than to limit the scope of the present invention. Various objects and advantages of the present invention will become apparent to those skilled in the art based on the following detailed description of the accompanying drawings and preferred embodiments. BRIEF DESCRIPTION OF THE DRAWINGS

[0074] Figure 1 This is an agarose gel (1.5%) representation of the PCR product amplified using primer pair I from the leech sample to be tested.

[0075] Figure 2 Agarose gel (1.5%) representation of the PCR product amplified using primer pairs II (WP1-WP10; PM1-PM2) and III (WL1-WL5) from the leech sample to be tested.

[0076] Figure 3 Agarose gel (1.5%) representation of the multiplex PCR products amplified using primer pairs II and III for the leech sample to be tested.

[0077] Figure 4 Agarose gel (1.5%) representation of the multiplex PCR products amplified using primer pairs II and III for the leech sample to be tested.

[0078] Figure 5 The amplified sequences of 17 batches of leech medicinal materials were amplified by PCR using primer pair I and the comparison results with the standard database.

[0079] Figure 6 The amplified sequences of 17 batches of leech medicinal materials were amplified by PCR using primer pair II or III and the comparison results with the standard database.

[0080] Sequence information

[0081] A description of the sequences involved in this application is provided in the table below.

[0082] Table 1: Sequence information

[0083]

[0084] DETAILED DESCRIPTION

[0085] The invention will now be described with reference to the following examples which are intended to illustrate the invention rather than to limit the invention.

[0086] Unless otherwise specified, the molecular biology experimental methods used in the present invention are basically carried out with reference to the methods described in J. Sambrook et al., Molecular Cloning: A Laboratory Manual, 2nd edition, Cold Spring Harbor Laboratory Press, 1989, and FM Ausubel et al., A Compendium of Molecular Biology Experiments, 3rd edition, John Wiley & Sons, Inc., 1995; the experimental methods used are conventional methods unless otherwise specified; the materials, reagents, etc. used, unless otherwise specified, can all be obtained from commercial channels.

[0087] The examples describe the present invention by way of example and are not intended to limit the scope of the present invention as claimed.

[0088] Example 1: Identification of Chinese medicinal leech by PCR

[0089] The Chinese medicine samples to be tested in this embodiment include Hirudo scutellariae, Hirudo glabrae and Hirudo philadelphicae (see Table 2 for details).

[0090] Table 2 Sample information

[0091]

[0092] Note: The samples of broad-bodied golden leech in the table comply with the relevant provisions under the main text of the Chinese Pharmacopoeia (2020 edition) under the medicinal materials item (WP10 is the medicinal material collected by Yangshengtang); the Philippine cattle leech complies with the relevant provisions under the corresponding medicinal materials item in the "Guangxi Zhuang Autonomous Region Zhuang Medicine Quality Standard Zhuang Pharmacopoeia" and the "Yunnan Province Traditional Chinese Medicine Standard"; the smooth golden leech complies with the relevant records under the corresponding species item in the "Fauna Sinica".

[0093] 1. Extraction of genomic DNA and PCR amplification

[0094] 1. Extraction of leech genomic DNA

[0095] Extract genomic DNA from the tested traditional Chinese medicine sample as a template, and the DNA extraction method is as follows: accurately weigh 10.0 mg of the tested leech sample into a 1.5 mL EP tube, add 1 mL of SDS lysis solution-proteinase K solution (995:5), vortex mix, incubate at 56° C. for 6 h, during which the EP tube is horizontally oscillated at 600 rpm, and centrifuge at 12000 rpm for 15 min after the incubation to obtain supernatant 1; add an equal volume of Tris balanced phenol solution to the supernatant 1, vortex mix, and centrifuge at 12000 rpm for 10 min to obtain supernatant 2; add an equal volume of Tris balanced phenol-chloroform-isopropanol (25:24:1) solution to the supernatant 2, vortex mix, and centrifuge at 12000 rpm for 10 min to obtain supernatant 3; add an equal volume of Chloroform-isopropanol (24:1) solution was vortexed and centrifuged at 12000rpm for 10min to obtain supernatant 4; 1 / 10 volume of 5M potassium acetate solution and an equal volume of pre-cooled isopropanol were added to the supernatant 4, vortexed and mixed, allowed to stand at -20°C overnight, and centrifuged at 12000rpm for 15min to obtain precipitate 1; 500μL of pre-cooled 70% ethanol was added to the precipitate 1, the precipitate was washed, centrifuged at 12000rpm for 15min, the solution was discarded, and the washing was repeated 3 times to obtain precipitate 2; the precipitate 2 was dried at room temperature, 100μL of sterile water was added to dissolve it, and the genomic DNA was obtained, which was stored at -20°C.

[0096] 2. PCR amplification

[0097] The primer sequences used for PCR amplification are as follows:

[0098] Primer pair I (designed based on ITS sequence), comprising primer IF: 5′-GGAGCCAGGCCTGTCTCAG-3′ (No. 1), and primer IR: 5′-GGTCTGACATTCTGGCAACC-3′ (No. 2);

[0099] Primer pair II (designed based on the COI sequence), comprising primer II.F: 5′-GCACAGCCAGGAAGATTCCTTGG-3′ (No. 3), and primer II.R: 5′-GGCTATGTCAACGGATGGGCC-3′ (No. 4);

[0100] Primer pair III (designed based on the COI sequence), comprising primer III.F: 5′-GGCGCATGAGCGGCTATATTGG-3′ (No. 5), and primer III.R: 5′-GGCTATGTCAACGGATGGGCC-3′ (No. 6).

[0101] PCR amplification was performed using the following primer pairs:

[0102] The PCR reaction was carried out in a 200 μL centrifuge tube. The total reaction volume was 25 μL, as follows: 12.5 μL of 2×M5 Hiper ultralight speed mix and 1 μL (100 ng) of template DNA, 1 μL of each of the forward and reverse identification primers (5 μmol·L-1), and sterile distilled water was added to 25 μL. Among them, 2×M5 Hiper ultralight speed mix is ​​a product of Beijing Poly-Biotech Co., Ltd., and its product number is MF848-01.

[0103] Amplification was performed on a T100-Thermal Cycler instrument from BIO-RAD with the following cycle parameters: pre-denaturation at 95°C for 3 min, 35 cycles (denaturation at 95°C for 30 s, annealing at 58°C or 60°C for 30 s, extension at 72°C for 1 min), and extension at 72°C for 5 min; storage at 4°C after the reaction was complete.

[0104] 2. Detection of amplification products

[0105] The PCR amplification products obtained above were detected by agarose gel electrophoresis. The detection results were as follows: Figure 1-2The inventors of the present application have found that, for the multiple batches of broad-bodied golden leech, smooth golden leech and Philippine cattle leech samples shown in Table 2, primer pair III can produce specific amplification bands in all batches of smooth golden leech, but no specific amplification bands are produced for broad-bodied golden leech and Philippine cattle leech samples, that is, primer pair III can specifically detect smooth golden leech in the three leech samples; primer pair II can produce specific amplification bands in all batches of broad-bodied golden leech and Philippine cattle leech samples. In addition, the inventors need to emphasize that since the broad-bodied golden leech and the Philippine cattle leech are very different in appearance, the broad-bodied golden leech and the Philippine cattle leech can be separated from each other in appearance. Therefore, based on the appearance distinction, the primer pair II of the present application can specifically detect the broad-bodied golden leech or the Philippine cattle leech; the primer pair I produces specific amplification bands in the broad-bodied golden leech, the smooth golden leech and the Philippine cattle leech samples.

[0106] Example 2, Verification of the Accuracy of the Identification Results of Example 1

[0107] 1. PCR product sequencing

[0108] The PCR product obtained in Example 1 was sent to GENEWIZ (Suzhou Genewiz Biotechnology Co., Ltd.) for sequencing.

[0109] 2. Verification Method

[0110] The amplified sequences of each batch of samples obtained in step 1 are compared with the standard sequences. If the COI sequence matching degree of the two is ≥98% and / or the ITS sequence matching degree is ≥90%, the sample to be tested is determined to be the corresponding species, thereby indicating that the primers of the present application have excellent accuracy for leech identification.

[0111] The standard sequence of the broad-bodied golden line leech is the COI nucleotide sequence shown in No. 7 and the ITS nucleotide sequence shown in No. 10 in the sequence list;

[0112] The standard sequences of Hirudophora glabrata are the COI nucleotide sequence shown in No.8 and the ITS nucleotide sequence shown in No.11;

[0113] The standard sequences of the Philippine leech are the COI nucleotide sequence shown in No. 9 and the ITS nucleotide sequence shown in No. 12;

[0114] The sequencing sequences of each sample after splicing the sequencing results were compared using DNAMAN 6.0 software, and it was found that the matching degree between the COI sequence and the ITS sequence of the wide-bodied golden line leech and the corresponding standard sequence was ≥98%; the matching degree between the COI sequence of the smooth golden line leech and the corresponding standard sequence was ≥98%, and the matching degree between the ITS sequence and the corresponding standard sequence was ≥91%.

[0115] The specific comparison results are as follows: the matching degree of the sequencing sequences of primer pair I of all samples of broad-bodied golden leech and Philippine cattle leech in Table 2 with the corresponding standard sequences No.10 and No.12 is ≥98%; the matching degree of the sequencing sequences of primer pair I of all samples of smooth golden leech with the corresponding standard sequence No.11 is ≥91%; the matching degree of the sequencing sequences of primer pair II of almost all samples of broad-bodied golden leech and Philippine cattle leech in Table 2 with the corresponding standard sequences No.7 and No.9 is ≥98% (only WP5 is 94%, which may be caused by individual differences or sequencing errors); the matching degree of the sequencing sequences of primer pair III of all samples of smooth golden leech in Table 2 with the corresponding standard sequence No.8 is ≥98% (see Figure 5-6 ).

[0116] The above results show that each batch of samples provided in Table 2 of the present application belongs to its corresponding leech species, which also shows that the primers provided by the present invention can quickly and accurately identify the corresponding species of traditional Chinese medicine leeches.

[0117] Example 3: Verification of specific primer specificity

[0118] The Chinese medicine samples to be tested in this embodiment include broad-bodied golden line leech, pointed golden line leech, Japanese medicinal leech, smooth golden line leech and Philippine cattle leech (see Table 3 for details)

[0119] Table 3 Sample information

[0120]

[0121]

[0122] Note: The samples of broad-bodied golden leech, Japanese medicinal leech and pointed golden leech in the table comply with the relevant provisions under the main text of the Chinese Pharmacopoeia (2020 edition) under the medicinal materials item (WP10 is the medicinal material collected by Yangshengtang); the Philippine cattle leech complies with the relevant provisions under the corresponding medicinal materials item in the "Guangxi Zhuang Autonomous Region Zhuang Medicine Quality Standard Zhuang Pharmacopoeia" and the "Yunnan Province Traditional Chinese Medicine Standard"; the smooth golden leech complies with the relevant records under the corresponding species item in the "Fauna Sinica".

[0123] 1. Genomic DNA Extraction and Multiplex PCR Amplification

[0124] 1. Extraction of leech genomic DNA

[0125] The leech genomic DNA was extracted according to Example 1.

[0126] 2. Multiplex PCR Amplification

[0127] The primers used for multiplex PCR amplification were the above-mentioned primer pair II (Nos. 3-4) and primer pair III (Nos. 5-6).

[0128] Multiplex PCR amplification was performed using primer pairs as follows:

[0129] Multiplex PCR reaction was performed in a 200 μL centrifuge tube. The total reaction volume was 25 μL, as follows: 12.5 μL of 2×M5 Hiper ultralight mix and 1 μL (100 ng) of template DNA, 1 μL of each of primer pairs II and III forward identification primers (5 μmol·L-1), 2 μL of total reverse primer (5 μmol·L-1), and sterile distilled water was added to 25 μL. Among them, 2×M5 Hiper ultralight mix is ​​a product of Beijing PolyMei Biotechnology Co., Ltd., and its product number is MF848-01.

[0130] Amplification was performed on a T100-Thermal Cycler instrument from BIO-RAD with the following cycle parameters: pre-denaturation at 95°C for 3 min, 35 cycles (denaturation at 95°C for 30 s, annealing at 60°C for 30 s, extension at 72°C for 1 min), and extension at 72°C for 5 min; storage at 4°C after the reaction was complete.

[0131] 2. Detection of amplification products

[0132] The multiple PCR amplification products obtained above were detected by agarose gel electrophoresis. The detection results are as follows Figure 3-4 As shown. As designed by the inventors of the present application, for the leech samples shown in Table 3, primer pair III can produce specific amplification bands in all batches of golden leeches, but no specific amplification bands are produced for other samples, that is, primer pair III can specifically detect golden leeches in the five leech samples, further verifying its specificity; primer pair II can produce specific amplification bands in all batches of broad-bodied golden leeches and Philippine cattle leeches, but no specific amplification bands are produced for other leech samples, further verifying its specificity. In addition, the inventors need to emphasize that since the broad-bodied golden leeches and Philippine cattle leeches are very different in appearance, the broad-bodied golden leeches and Philippine cattle leeches can be separated from each other in appearance. Based on this, the primer pair II of the present application can specifically detect broad-bodied golden leeches or Philippine cattle leeches.

[0133] Although the specific embodiments of the present invention have been described in detail, it will be understood by those skilled in the art that various modifications and changes may be made to the details according to all the teachings that have been published, and these changes are within the scope of protection of the present invention. The entire invention is given by the attached claims and any equivalents thereof.

Claims

1. A primer set comprising: (i) a primer A having a sequence as shown in SEQ ID NO:5 and a primer B having a sequence as shown in SEQ ID NO:6; or (ii) a primer A' having a sequence as shown in SEQ ID NO:3 and a primer B' having a sequence as shown in SEQ ID NO:

4.

2. A method for identifying a leech sample, the method being used to identify whether the leech sample to be tested is Hirudo glabrata, Hirudo glabrata or Hirudo philadelphica, comprising the step of using the primer set of claim 1.

3. The identification method of claim 2, wherein include: (1) providing: nucleic acid derived from the leech sample to be tested, and the primer set of claim 1; (2) contacting the nucleic acid derived from the leech sample to be tested with the primer set of claim 1, and performing a PCR reaction; (3) Evaluate whether the leech sample to be tested is Hirudo glabra, Hirudo glabra or Hirudo philadelphica.

4. The identification method of claim 3, in, The nucleic acid derived from the leech sample to be tested is DNA (e.g., genomic DNA); Preferably, in step (1), the identification method provides nucleic acid derived from the leech sample to be tested by extracting and / or purifying nucleic acid from the leech sample to be tested.

5. The identification method according to claim 3 or 4, in, In step (3), whether the leech sample to be tested is Hirudo glabrata, Hirudo latifolia and / or Hirudo philadelphica is determined by detecting the specific amplification product of the PCR reaction.

6. The identification method according to any one of claims 3 to 5, in, The primer set is as defined in claim 1 (i); Preferably, in step (3), if there is a PCR reaction-specific amplification product, it indicates that the leech sample to be tested is Hirudophora glabrata.

7. The identification method according to any one of claims 3 to 5, in, The primer set is as defined in claim 1 (ii); Preferably, in step (3), if there is a PCR reaction-specific amplification product, it indicates that the leech sample to be tested is Hirudo philadelphica or Hirudo philadelphica; For example, in step (3), if there is a PCR reaction-specific amplification product, and the leech sample to be tested has the appearance characteristics of the broad-bodied golden line leech, it indicates that the leech sample to be tested is the broad-bodied golden line leech; For example, in step (3), if there is a PCR reaction-specific amplification product, and the leech sample to be tested has the appearance characteristics of Hirudo philadelphica, then it indicates that the leech sample to be tested is Hirudo philadelphica.

8. A method for detecting whether a sample to be tested contains a golden leech, comprising the step of using a primer set, wherein the primer set comprises: a primer A having a sequence as shown in SEQ ID NO: 5 and a primer B having a sequence as shown in SEQ ID NO: 6; Preferably, the detection method include: (1) providing: a nucleic acid derived from the sample to be tested, and the primer set; (2) contacting the nucleic acid derived from the sample to be tested with the primer set and performing a PCR reaction; (3) Evaluate whether the sample to be tested contains Hirudovirus glabrata.

9. The detection method according to claim 8, in, The nucleic acid derived from the sample to be tested is DNA (e.g., genomic DNA); Preferably, in step (1), the detection method provides nucleic acid derived from the sample to be tested by extracting and / or purifying nucleic acid from the sample to be tested.

10. The detection method according to claim 8 or 9, in, In step (3), whether the sample to be tested contains Hirudophora glabrata is determined by detecting the specific amplification product of the PCR reaction; For example, in step (3), if there is a specific amplification product of the PCR reaction, it indicates that the sample to be tested contains Hirudophora glabrata.

11. A kit comprising: (a) a first primer having a sequence as shown in SEQ ID NO: 5, and / or a second primer having a sequence as shown in SEQ ID NO: 3; as well as, (b) a third primer having a sequence as shown in SEQ ID NO: 6 or 4.

12. Use of the primer set of claim 1 or the kit of claim 11 in detecting Hirudo glabrata, Hirudo glabrata and / or Hirudo philadelphus, or in preparing a detection reagent for detecting Hirudo glabrata, Hirudo glabrata and / or Hirudo philadelphus.